BioSpace News Archive

Exscientia plc announced that members of Exscientia management will participate in the following upcoming investor conferences in September: 2023 Wells Fargo Healthcare Conference.

Enanta Pharmaceuticals, Inc. announced that members of management will participate in four investor conferences being webcast in September and provide a business update: Wells Fargo Securities Healthcare Conference: Fireside Chat at 2:15 p.m. ET on September 7, 2023 H.C.

CareDx, Inc. announced that the Company will participate in the H.C. Wainwright 25th Annual Global Investment Conference.

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) today announced that presentations from its bioMUSE natural history study of Multiple System Atrophy (MSA) were delivered at the International Congress of Parkinson’s Disease and Movement Disorders (MDS) taking place August 27 - 31, 2023 in Copenhagen, Denmark.

Zevra Therapeutics, Inc. and Acer Therapeutics Inc. announced the companies have entered into a definitive agreement pursuant to which Zevra would acquire Acer in a merger transaction having a total potential value for Acer stockholders of up to $91 million.

Fate Therapeutics, Inc. announced that the Company will participate in the following upcoming investor conferences.

Vera Therapeutics, Inc. announced that the Company’s management team will present and participate in one-on-one meetings at four investor conferences being held next month.

BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced it will host a virtual KOL event titled NE3107―Putting Data in Context, ahead of the upcoming Phase 3 results in Alzheimer’s Disease.

Idorsia Pharmaceuticals U.S. Inc. announced that Tausif Butt will join the organization as the new President and General Manager on September 5, 2023.

BrainTale, a medtech deciphering white matter to enable better brain care, spin-off of the Paris Region Greater Hospitals, presented the benefits of using its biomarkers technology in real-life conditions during the 35th annual meeting of the Eastern NeuroRadiology Society (ENRS).